Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma

Published:2017-08-01 Issue:10 Volume:47 Page:1239-1245
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Jabbal S.¹^ORCID,Manoharan A.¹,Lipworth B. J.¹

Affiliation:

1. Scottish Centre for Respiratory Research; Ninewells Hospital and Medical School; University of Dundee; Dundee UK

Funder

Departmental Unrestricted Educational Grant

Pharmaxis, Sydney, Australia

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cea.12972/fullpdf

Reference43 articles.

1. Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD;Moulton;Br J Pharmacol,2011

2. Tiotropium in asthma poorly controlled with standard combination therapy;Kerstjens;N Engl J Med,2012

3. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial;Kerstjens;J Allergy Clin Immunol,2011

4. What are minimal important changes for asthma measures in a clinical trial?;Santanello;Eur Respir J,1999

5. Tiotropium in asthma;Lipworth;N Engl J Med,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement;Expert Opinion on Pharmacotherapy;2024-05-23

2. The 5T approach in asthma: Triple Therapy Targeting Treatable Traits;Respiratory Medicine;2022-08

3. Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma;JAMA;2021-06-22

4. Inhaled triple therapy and airway hyperresponsiveness in persistent asthma;Annals of Allergy, Asthma & Immunology;2021-05

5. Randomized controlled trial of triple versus dual inhaler therapy on small airways in smoking asthmatics;Clinical & Experimental Allergy;2020-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3